What are TRLV's recent SEC filings?
Trulieve Cannabis Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification. The certification confirms the financial statements fairly present the company's financial condition and results of operations.
View full filing details →Trulieve Cannabis Corp. reported third quarter 2026 financial results with revenue of $230 million, 64% gross margin, and adjusted EBITDA of $89 million. The company also received final DEA registrations for state-licensed medical marijuana dispensaries under Schedule III rescheduling.
View full filing details →Has TRLV ever done a stock split?
No stock splits are recorded for TRLV.
What is TRLV's share float?
Get Real-Time TRLV Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free